HealthEquity Catalysts Intact After Q2 Beat, RBC Says

MT Newswires Live08-28 23:40

HealthEquity (HQY) delivered better-than-expected Q2 results, keeping its margin runway and fiscal 2028 catalysts intact, RBC Capital Markets said in a Thursday note.

The report pointed to a record 48% adjusted EBITDA margin, driven by continued AI-enabled service cost reductions.

The note said a slower HSA cash-balance growth reflects a deliberate strategy toward higher-value investment accounts and

Marketplace engagement. It said the strategy is "accretive" rather than a degradation of the model.

"Marketplace and Bronze plan enrollment represent emerging catalysts," the report said. The firm's primary offerings are based on the administration of health savings accounts and other consumer-directed benefits.

RBC kept its outperform rating and a price target of $108.

Price: 96.20, Change: +2.81, Percent Change: +3.01

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment